WCC-2023
 

Online Registration

Hosting Organization

World High Technology Society

Overseas Cooperate Medias and Journals

Scientific Program




Program

Time: July 22-24, 2023

Venue: Catalonia Barcelona Plaza, Spain

 

 

Keynote Forum

Time: 09:10-12:10, July 22, 2023 (Saturday); Place: Catalonia Barcelona Plaza, Spain

 

Moderator

To Be Confirmed Soon

 

09:10-09:15

Moderator's Introduction

09:15-09:40

Title: The Origin of Bladder Cancer

Dr. Bogdan Czerniak, Professor, The University of Texas M. D. Anderson Cancer Center, USA

09:40-10:05

Title: TBD
Dr. Russel J. Reiter, Professor, University of Texas Health Science Center, USA

10:05-10:30

Title: TBD
Mr. Tim Shinbara, Vice President and CTO, The Association for Manufacturing Technology, USA

10:30-10:55

Title: TBD
Dr. James Wang, Professor and Director of the eVTOL Research & Innovation Centre, Nanyang Technological University, Singapore

10:55-1120

Title: TBD
Dr. Hans-Jorg Fecht, Chaired Professor and Director, Ulm University, Germany

11:20-11:45

Title: TBD
Dr. Samuel Kenig, Professor, Vice President and Director of the Research and Development Authority, Shenkar College of Engineering and Design, Israel

11:45-12:10

Title: Prospects for Targeted Protein Degraders in the Fight Against Aggressive Cancer
Dr. Vehary SAKANYAN, Professor, Nantes University, ProtNeteomix, France

 

 

WCC 01:  Cancer Cell Biology & Genetics

Time: 14:00-18:20, July 22, 2023 (Saturday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel

Co-Chair

Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong of China

 

14:00-14:05

Chair's Introduction

14:05-14:25

Keynote Speech
Title: The Nuclear Translocation of ERK as a Therapeutic Target for Cancer and Inflammation

Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel

14:25-14:45

Title: TBD
Dr. Loannis Papasotiriou, Medical Director, R.G.C.C. INTERNATIONAL GmbH, Switzerland

14:45-15:05

Title: The Molecular Signature of Metastasis in the Early Stages of Clear Cell Renal Cell Carcinoma
Dr. Xinhua Zhu, Associate Professor, Northwell Health Cancer Institute, USA

15:05-15:25

Title: The Ubiquitin-Independent Protein Degradation Pathway In Cancer Progression
Dr. Henry James Li, Professor of Biochemistry, New York University-Shanghai, China

15:25-15:45

Title: Elucidating Osteoclast-Breast Tumor Hybrids Cell Fusion Mechanisms for Bone Metastatic Disease Progression
Dr. Kwan T. Chow, City University of Hong Kong, China

15:45-16:00

Coffee Break

16:00-16:20

Title: Dissecting the Molecular Heterogeneity of Young-onset Colorectal Cancer
Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong, China

16:20-16:40

Title: Human RNASET2: A Highly Pleiotropic Tumor Suppressor Gene Involved in Establishing a Complex Crosstalk between Cancer Cells and the Tumor Microenvironment
Dr. Francesco Acquati, Associate Pofessor, University of Insubria, Italy

16:40-17:00

Title: Intricating Membrane Transport and Metabolism with Intracellular pH Regulation. Insights into Mechanisms, Robustness, And Functional Redundancy

Dr. Laurent Counillon, Professor, Université Nice-Sophia Antipolis, France

17:00-17:20

Title: Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
Dr. Da Jung Kim, Director of Metabolomics Core facility, Seoul National University Hospital, South Korea

 

17:20-17:40

Title: The Role of Genomic Structural Variants in Prognosis and Treatment of Cancer

Dr. James R. Broach, Distinguished Professor and Chair, Penn State College of Medicine, USA

17:40-18:00

Title: The p 207 S LysRS–Ap4A–Hint-1–MITF Pathway in Health and Diseases

Dr. Ehud Razin, Professor, Hebrew University Hadassah Medical School, Israel

18:00-18:20

Speech Opportunity Available

 

 

 

WCC 02: Anti-Cancer Drug Discovery and Development

Time: 08:30-12:30, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA

Co-Chair

Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA

 

08:30-08:35

Chair's Introduction

08:35-08:55

Title: TBD

Dr. Zvi  Naor, Professor, Tel Aviv University, Israel

08:55-09:15

Title: Ablation rate and Thyroglobulin Decrease after Low-dose 131-I in Differentiated Thyroid Carcinoma Post-Total Thyroidectomy at Vietnam National Cancer Hospital

Dr. Duong Duc Binh, National Cancer Hospital (K hospital), Hanoi, Vietnam

09:15-09:35

Title: Anticancer Activity of Selected Plants of Israel and Palestine
Dr. Abdullatif Azab, Researcher, Eastern Plants Company, Israel

09:35-09:55

Title: ME-503 for Immune-Oncology Treatment: A Novel Mode of Action

Dr. Hans Lentzen, Managing Director, MELEMA Pharma GmbH, Germany

09:55-10:15

Title: Targeting Ibrutinib Resistance in B Cell Lymphoma

Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA

10:15-10:30

Coffee Break

10:30-10:50

Title: Molecular Mechanisms of Colon Tumorigenesis and Chemoresistance

Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA

10:50-11:10

Title: Chemo-Immunotherapy of Nanomedicine and anti-PD-1 antibody for Reprogramming Tumor Microenvironment to Overcome anti-PD-1 antibody-Resistance
Dr. Hiroaki Kinoh, Principal Researcher, Innovation Center of NanoMedicine, Japan

11:10-11:30

Title: Finding a Potential Prognostic Biomarker with Analyzing A Serum Soluble CD26/DPP4 Titer Variation from Baseline in Cancer Treatment on Patients with CD26+Tumor in Phase I and Phase I/II Clinical Trials by a Humanized anti-CD26 Monoclonal Antibody Therapy

Dr. Yutaro Kaneko, CEO, Juntendo University, Tokyo, Japan

11:30-11:50

Title: TBD

Dr. Dorit Avni, Sphingolipids, MIGAL - Galilee Research Institute, Israel

11:50-12:10

Title: Anti Cancer : Rational Design by Trojan Horse Strategy 

Dr. Nohad Al Omar, College of Pharmacy, Knowledge university, Iraq

12:10-12:30

Speech Opportunity Available

 

 

 

WCC 03: Cancer Therapy & Treatments-Part I

Time: 08:30-12:10, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Hariprasad Vankayalapati, Chief Scientific Officer, Biolexis Therapeutics, Inc., USA

Co-Chair

Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA

 

08:30-08:35

Chair's Introduction

08:35-08:55

Title: Haemorrhagic Small Bowel Melanoma Metastasis: A Clinical Rarity

Dr. Alexandros Zoumpos, Physician, Helios Klinik Herzberg/Osterode, Germany

08:55-09:15

Title: Measurement of Small Blood and Lymphatic Vessels in the Brain Using Novel MRI Techniques
Dr. Jun Hua, Associate Professor, Johns Hopkins University School of Medicine, USA

09:15-09:35

Title: Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer 

Dr. Serena Sestini, Regional Melanoma Referral Center, USA

09:35-09:55

Title: Manufacturing Control of Investigational CAR-T- cell products: Standards, Guidelines and Opportunities

Dr. Devanjan Sikder, Associate Director, Memorial Sloan-Kettering Cancer Center, USA

09:55-10:15

Title: CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma
Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA

10:15-10:30

Coffee Break

10:30-10:50

Title: Labyrinthin Moves from Bench-To-Clinic as Both Neo- And Pan-Adenocarcinoma Target
Dr. Michael Babich, Co-Founder and CEO, LabyRx Immuno-Oncology, Sacramento, USA

10:50-11:10

Title: Mechanisms underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models

Dr. Jing H. Wang, Professor, UPMC Hillman Cancer Center, University of Pittsburgh, USA

11:10-11:30

Title: AI/ML Driven Discovery and Development of Cancer Immunotherapeutics Through Small Molecules and Targeted Protein Degraders
Dr. Hariprasad Vankayalapati, Chief Scientific Officer, Biolexis Therapeutics, Inc., USA

11:30-11:50

Title: A Novel Genetically Engineered Blood System for Cancer Therapy

Dr. James Che-Kun Shen, Chair Professor, Taipei Medical University, Taipei, Taiwan

11:50-12:10

Speech Opportunity Available

 

 

WCC 04: Clinical Oncology

Time: 14:00-18:20, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Junichi Arita, Professor, Department of Gastroenterological Surgery, Akita University, Japan

Co-Chair

Dr. Andrew H Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA

 

14:00-14:05

Chair's Introduction

14:05-14:25

Title: Female Students’ Knowledge, Beliefs, Attitude and Practice of Breast Self-Examination in a University in the Western Cape

Ms. Mavis Bobie Ansah, Oncology Nurse Specialist, Komfo Anokye Teaching Hospital, Ghana  

14:25-14:45

Title: Hepatic Resections an Liver Transplantation: Signaling Pathways Involved in Protection Against Hepatic Ischemia-Reperfusion Damage and Liver Regeneration Failure: role of liver-adipose tissue axis

Dr. Carmen Peralta, Senior Group Leader, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Spain

14:45-15:05

Title: Repeat Resection of Neuroendocrine Liver Metastases and Possibility of Cure
Dr. Junichi Arita, Professor, Department of Gastroenterological Surgery, Akita University, Japan

15:05-15:25

Title: Systemic Chemotherapy for Soft Tissue Sarcoma Rather than Liver, Pancreatic And Biliary Tract Cancer

Dr. Hiroyuki Narahara, Director of Clinical Research Center, Hyogo Prefectural Nishinomiya Hospital, Japan

15:25-15:45

Title: ROS Homeostasis and Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma

Dr. Eunyoung Tak, Associate Professor, University of Ulsan College of Medicine, South Korea

15:45-16:00

Coffee Break

16:00-16:20

Title: Impact of Viral Burden and Trajectory of Hepatocellular Carcinoma in Armenia

Dr. Hasmik Ghazinyan, Nork Clinical Hospital of Infectious Diseases, Yerevan , Armenia

16:20-16:40

Title: Reconstructive Surgery of the Upper Lip after Combined Resection of the Upper Lip and Buccal Mucosa for Oral Cancer

Dr. Kazuhide Matsunaga, Associate Professor, Osaka University, Japan

16:40-17:00

Title: Up-date: Use of 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) as Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Involving the CNS

Dr. Andrew H Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA

17:00-17:20

Title: Advanced Oral Cancers Surgical Management 

Dr. Harsh Dhar, Consultant Head Neck and Skull Base Surgeon, Medica Superspeciality Hospitals & Cancer Centre, India

17:20-17:40

Title: Rare Cutaneous Tumors: A Case Report of Angiosarcoma and Primary Cutaneous Lymphoma

Dr. Typhannie Coelho Borges Silva, Tocantinense University Center Presidente Antônio Carlos - UNITPAC, Brazil

17:40-18:00

Title: Updates in Thyroid Nodules Management
Dr. Thanh D. Hoang, Program Director, Walter Reed National Military Medical Center, USA

18:00-18:20

Speech Opportunity Available

 

WCC 05: Cancer Therapy & Treatments-Part II

Time: 08:30-12:10, July 24, 2023 (Monday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Thomas Böldicke, Senior Scientist, Department Structure and Function of Proteins, Helmholtz Centre for Infection Research, Germany

Co-Chair

Dr. Jerome H. Check, Professor, Cooper Medical School of Rowan University, USA

 

08:30-08:35

Chair's Introduction

08:35-08:55

Title: Treatment with Progesterone Antagonists May Be the Key to Converting Many End-Stage Cancers Into a Chronic Disease With Low Morbidity
Dr. Jerome H. Check, Professor, Cooper Medical School of Rowan University, USA

08:55-09:15

Title: Targeting Microtubule Stabilization to Reduce Breast Cancer Metastasis
Dr. Stuart S. Martin, Deputy Director, Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, USA

09:15-09:35

Title: Absorbed Dose and Its Determination in Hadrontherapy

Dr. Grazia Gambarini, Associate Professor, Department of Physics, Università degli Studi di Milano, National Institute of Nuclear Physics (INFN), Section of Milano, Italy

09:35-09:55

Title: Therapeutic Inhibitors of Progression of Neuroblastoma Cells

Dr. Nada Al-Hasawi, Kuwait University, Kuwait

09:55-10:15

Title: Triple Negative Breast Cancer Therapy: A Novel Approach

Dr. Antonio Ponzetto, Retired Professor of Gastroenterology University of Torino, Torino, Italy

10:15-10:30

Coffee Break

10:30-10:50

Title: Mature TERATOMA in the Right Ventricle

Dr. Fekede D Agwar, Addis Ababa University, Ethiopia

10:50-11:10

Title: The Role of SNAIL 1 and SNAIL 2 Transcriptional Factors in the Development Of Ovarian Cancer Cells’ Chemoresistance in the Context of Their Metastatic Potential
Dr. Michal Kielbik, Assistant Professor, Institute of Medical Biology, Polish Academy of Sciences, Poland 

11:10-11:30

Title: Pigmented Lesion on the Face: Which is The Chance of Being Melanoma Using Reflectance Confocal Microscopy Features

Dr. Fernanda Mendes, Physician, AC Camargo Cancer Cente, Brazil

 

11:30-11:50

Title: Therapeutic Potential of Intrabodies Against Neoantigens: Current Status And Future Directions
Dr. Thomas Böldicke, Senior Scientist, Department Structure and Function of Proteins, Helmholtz Centre for Infection Research, Germany

11:50-12:10

Speech Opportunity Available

 

WCC 06: Oncology Nursing and Prevention

Time: 14:00-18:00, July 24, 2023 (Monday); Place: Catalonia Barcelona Plaza, Spain

 

Chair

Dr. Jacqueline T. Norrell, Director, Rutgers Cancer Institute, USA

 

14:00-14:05

Chair's Introduction

14:05-14:25

Title: Complexity of Care and Nursing Management of Toxicities in Cancer Patients Receiving Immunotherapy Including Cellular Therapy Treatments: The New Phenotype
Dr. Jacqueline T. Norrell, Director, Rutgers Cancer Institute, USA

14:25-14:45

Title: Improving Medication Adherence and Symptom Management in Patients with Cancer 

Dr. Carla Schaefer, Associate Chief Nursing Officer, The State University of New Jersey, USA

14:45-15:05

Title: Innovation in Ambulatory Cancer Care-Memorial Sloan Kettering Cancer Center
Dr. Geema Shetty Masson, Associate Attending Anesthesiologist, Memorial Sloan Kettering Cancer Center, USA 

15:05-15:25

Title: Outpatient Palliative Care for Advance Cancer Patients: Implementation of a Day Hospital

Dr. Laura Thery, Consultant, Institut Curie, France

15:25-15:45

Title: Coping Strategies and Their Impact on Emotional Distress and Fatigue Among Breast Cancer Survivors

Dr. Inbar Levkovich, Associate Professor, Oranim Academic College of Education, Israel

15:45-16:00

Coffee Break

16:00-16:20

Title: Cognitive deficits and psychopathological symptoms among children with medulloblastoma

Dr. Annamária Szentes, Clinical Child Psychologist, 2nd Department of Paediatrics, Semmelweis University, Hungary

16:20-16:40

Title: Epidemiology of Breast Cancer In Women Based On Diagnosis Data From Oncologists And Senologists In Algeria

Dr. A Boudjella, Blida 1 University, Algeria

 

16:40-17:00

Title: Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules 

Dr. Aline Machado Larcher de Almeida, School of Medicine of Federal University of Rio de Janeiro, Brazil   

 

17:00-17:20

Title: Production and Prebiotic Properties of Oligofructans from Sugarcane Juice Fermentation by Bacillus subtilis TISTR 001
Dr. Boontiwa Ninchan, Assistance Professor, Sugars and Derivatives Analytical Laboratory, Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Thailand

 

17:20-17:40

Title: The Impact of Social Vulnerability on Time to Treatment Disparities Among Insured Adult Patients with Metastatic Cancers
Dr. Teresa M. Zyczynsk, Director, Customer Strategy & Solutions, Bristol-Myers Squibb, USA

17:40-18:00

Speech Opportunity Available

 

Video

1

Title: Predicting Response to Immunotherapy in Head and Neck Cancer
Dr. Priyanka Bhateja, Assistant Professor, The Ohio State University, USA

2

Title: TBD
Dr. Zoe S. Walters, Lecturer, Southampton University, USA

3

Title: Molecular Iodine in Chemoresistant Cancers

Dr. Carmen Aceves, Universidad Nacional Autómona de México, México

4

Title: TRIM32 Promotes Radioresistance by Disrupting TC45-STAT3 Interaction in Triple-Negative Breast Cancer

Dr. Jianming Tang, Zhejiang Provincial People' s Hospital, People' s Hospital of Hangzhou Medical College, China

5

Title: TBD
Dr. Yonglei Liu, Zhongshan Hospital Qingpu Branch, Fudan University, China

6

Title: Assessment of Extremely Low Frequency Electromagnetic Field Exposure In Children In Residential Settings through Machine Learning

Dr. Gabriella Tognola, Cnr-Istituto di Elettronica e di Ingegneria dell’Informazione e delle Telecomunicazioni (CNR-IEIIT) Milano, Italy

7

Title:  Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients - Full Text View - ClinicalTrials.gov

Dr. Aditya Shreenivas, Assistant Professor, Medical College of Wisconsin, USA

9

Title: Repeat periods of electrical stimulation prolong the modulation of the micturition reflex in the rat

Dr. Chonghe Jiang, The Sixth Affiliated Hospital of Guangzhou Medical University, China

10

Title: TBD
Dr. Mohammed  Abdulaziz  Aldawish, PSMMC, Saudi Arabia



 

Hosting Organization

Official Travel Agency

 

Media

Partners

Contact Us

Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China

© 2003-2023 All rights reserved by BIT Congress